Results 81 to 90 of about 1,421,660 (159)

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma

open access: yesPediatric Rheumatology Online Journal, 2018
Objectives To assess reliability of the two indexes of Localized Scleroderma Cutaneous Assessment Tool (LoSCAT), the modified Localized Scleroderma Skin Severity Index (mLoSSI) and the Localized Scleroderma Skin Damage Index (LoSDI), when applied by ...
Anna Agazzi   +4 more
doaj   +1 more source

MicroRNA in localized scleroderma: a review of literature

open access: yesArchives of Dermatological Research, 2019
Localized scleroderma (LoSc) is rare connective tissue disease that manifests with inflammation and fibrosis of the skin. Depending on the LoSc subtype, adjacent structures such as subcutaneous tissue, fascia, muscles, bones may be affected. The hallmark
Katarzyna Wolska-Gawron   +2 more
semanticscholar   +1 more source

Ultrasonography, MRI and classic radiography of skin and MSK involvement in juvenile scleroderma

open access: yesJournal of Ultrasonography, 2020
Scleroderma is a rare, autoimmune, chronic condition that affects the connective tissue by excessive collagen production. If diagnosed before the age of 16, it is referred to as juvenile scleroderma.
Idzior Marta   +4 more
doaj   +1 more source

Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma

open access: yesJournal of Rheumatology, 2019
Objective. To perform a comparative effectiveness feasibility study in juvenile localized scleroderma (LS), using standardized treatment regimens (consensus treatment plans; CTP). Methods.
Suzanne C. Li   +14 more
semanticscholar   +1 more source

Parry-Romberg Syndrome Associated with Localized Scleroderma

open access: yesCase Reports in Neurology, 2010
Parry-Romberg syndrome is a rare neurocutaneous disorder of unknown origin. It is characterized by progressive facial hemiatrophy and frequently overlaps with a condition known as linear scleroderma ‘en coup de sabre’.
Jelena Maletic   +4 more
doaj   +1 more source

A case of localized bullous scleroderma

open access: yesVestnik Dermatologii i Venerologii, 2017
Bullous scleroderma is a rare type of the focal form of the disease mainly affecting the skin and characterized by induration and sclerosis foci as well as subepidermal blisters containing a transparent matter.
A. L. Bakulev   +3 more
doaj   +1 more source

Localized scleroderma (morphea). Diagnostic and therapeutic recommendations of the Polish Dermatological Society

open access: yesDermatology Review, 2019
Localized scleroderma (morphea) is a chronic autoimmune disease of the connective tissue. Its etiopathogenesis is unknown. Most often the disease affects the skin, but may also involve the subcutis, muscles, and the osteoarticular system.
D. Krasowska   +10 more
semanticscholar   +1 more source

A novel patient‐reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity

open access: yesBritish Journal of Dermatology, 2019
According to current standards, no existing patient‐reported outcome (PRO) measures have high‐quality validity evidence for use with individuals diagnosed with paediatric localized scleroderma (LS).
C. Zigler   +4 more
semanticscholar   +1 more source

Experience with Lipofilling in Children with Localized Scleroderma: Case Study

open access: yesВопросы современной педиатрии
Background. Localized scleroderma (LS) is an inflammatory sclerosing disease of unknown etiology. It is characterized by progressive lesion of connective tissue leading to sclerosis and/or atrophy of the skin and underlying tissues.
Alina R. Misbakhova   +4 more
doaj   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Home - About - Disclaimer - Privacy